Moody National Bank Trust Division Insmed Inc Transaction History

Moody National Bank Trust Division

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$23.0 - $32.19 $2,990 - $4,184	-130 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$13.91 - $31.15 $2,114 - $4,734	-152 Reduced 53.9%	130 $4,000
Q4 2018 Jan 07, 2019	BUY	$11.6 - $18.7 $3,271 - $5,273	282 New	282 $4,000

475

179M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.